Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial

医学 结直肠癌 放化疗 肿瘤科 腺癌 新辅助治疗 内科学 化疗 佐剂 临床试验 外科 癌症 乳腺癌
作者
Maria Widmar,Mason McCain,Akriti Mishra Meza,Charles A. Ternent,Andrew Briggs,Julio García‐Aguilar
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
被引量:2
标识
DOI:10.1200/jco.24.00681
摘要

PURPOSE The clinical efficacy of total neoadjuvant therapy (TNT) followed by selective nonoperative management (NOM) for locally advanced rectal cancer (LARC) was examined in the Organ Preservation for Rectal Adenocarcinoma (OPRA) trial. We investigated the cost and quality-of-life implications of adopting this treatment approach. METHODS We analyzed clinical, cost, and quality-of-life outcomes for TNT with selective NOM in comparison with chemoradiotherapy (CRT)-surgery-adjuvant chemotherapy (standard of care [SOC]) using data from OPRA, prospective cohorts, and published studies. Cost-effectiveness was evaluated over varying willingness-to-pay thresholds, and sensitivity analyses evaluated cost-effectiveness for different surgical contexts and SOC variants as well as a 10-year time horizon. RESULTS SOC was dominated by TNT with selective NOM in the base case analysis. TNT in which CRT was followed by consolidation chemotherapy (CNCT) was the least costly at $89,712 in Medicare proportionate US dollars (MP$), followed by TNT in which induction chemotherapy was followed by CRT (INCT) at MP$90,259 and SOC at MP$98,755. INCT was the preferred strategy, with 4.56 quality-adjusted life years, followed by CNCT at 4.42 and SOC at 4.29. TNT with selective NOM dominated SOC in all sensitivity analyses except when SOC omitted adjuvant chemotherapy without an impact on disease-free survival. CNCT was more cost effective than SOC when the proportion of patients entering NOM after TNT was ≥22% or ≥43%, for SOC with and without adjuvant therapy, both well below the rates seen in OPRA. CONCLUSION TNT with selective NOM is cost effective. The cost-effectiveness of CNCT with NOM relative to SOC is dependent on CNCT being made available to a sufficiently large proportion of patients with LARC. Additional analyses are needed to validate these findings from a societal perspective and in the context of other emerging treatment paradigms for LARC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
wang的应助被ychope采纳,获得20
1秒前
慕青的应助被单薄雪巧采纳,获得10
2秒前
111发布了新的文献求助10
2秒前
CodeCraft的应助被Ov5采纳,获得10
2秒前
111发布了新的文献求助10
3秒前
肆月完成签到 ,获得积分10
3秒前
njseu完成签到 ,获得积分10
3秒前
wangrch6完成签到,获得积分10
5秒前
噜噜噜完成签到,获得积分10
6秒前
祈祷spring发布了新的文献求助10
6秒前
认真初之完成签到,获得积分10
7秒前
ma驳回了晚晚的应助
7秒前
HY发布了新的文献求助10
7秒前
梦真完成签到,获得积分10
10秒前
10秒前
10秒前
CodeCraft的应助被XY采纳,获得10
11秒前
11秒前
乐乐的应助被Jiang采纳,获得10
11秒前
Ziyi_Xu完成签到,获得积分10
13秒前
manstein发布了新的文献求助10
14秒前
Huo完成签到,获得积分10
14秒前
hzm完成签到,获得积分10
14秒前
大成子发布了新的文献求助10
14秒前
14秒前
淡然寒梅发布了新的文献求助10
15秒前
15秒前
Ava的应助被小事化小面包采纳,获得10
15秒前
15秒前
好好学习天天向上完成签到 ,获得积分10
15秒前
16秒前
Zack发布了新的文献求助10
16秒前
16秒前
17秒前
18秒前
18秒前
Beagle完成签到,获得积分10
18秒前
SciGPT的应助被如意2023采纳,获得10
18秒前
体贴千山完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193335
求助须知:如何正确求助?哪些是违规求助? 9579489
关于积分的说明 21865844
捐赠科研通 7792843
什么是DOI,文献DOI怎么找? 3437210
关于科研通互助平台的介绍 2560687
邀请新用户注册赠送积分活动 2483996